Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 96 holding rows worth $3,080,209,000.

Accession
0001791827-21-000002
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 96 entries on the cover page, a total value of $3,080,209,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,080,209,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVANTOR INC COM05352A100Stock6,566,700$184,853,000thousands by filing date
ARVINAS INC04335A105COM1,787,358$151,800,000thousands by filing date
AbbVie,Inc.00287Y109COM1,356,000$145,295,000thousands by filing date
Eli Lilly and Company532457108COM810,500$136,845,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR2,300,000$114,977,000thousands by filing date
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK3,445,772$96,654,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock792,100$94,395,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM992,900$87,067,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS1,169,300$85,534,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM380,000$83,463,000thousands by filing date
NOVABRIDGE BIOSCIENCES44975P103CMN1,591,000$75,016,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM3,308,000$73,570,000thousands by filing date
BIOGEN INC09062X903CALL248,100$60,749,000thousands by filing datecall
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,135,000$58,952,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM3,082,100$57,481,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK938,813$49,203,000thousands by filing date
NATERA INC COM632307104Stock479,800$47,750,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW621,000$47,711,000thousands by filing date
CHEMOCENTRYX INC16383L106COM757,000$46,873,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock3,185,200$46,854,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM521,100$44,663,000thousands by filing datecall
APELLIS PHARMACEUTICALS INC03753U106COM774,000$44,273,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM808,000$43,276,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM491,800$42,152,000thousands by filing date
ORGANOGENESIS HOLDINGS INC68621F102COMMON STOCK5,521,500$41,577,000thousands by filing date
BAUSCH HEALTH COS INC COM071734107Stock1,972,000$41,018,000thousands by filing date
KADMON HLDGS INC48283N106COM9,570,000$39,716,000thousands by filing date
ACCELERON PHARMA INC00434H108COM299,000$38,254,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM217,400$37,065,000thousands by filing date
ATHIRA PHARMA INC04746L104COM1,043,873$35,753,000thousands by filing date
Medtronic PlcG5960L103COM301,000$35,259,000thousands by filing date
CATALENT INC USD 0.01148806102COM337,000$35,072,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM147,300$34,813,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM731,000$33,085,000thousands by filing date
SIGILON THERAPEUTICS INC82657L107COM688,000$33,045,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock247,000$32,725,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW2,558,000$30,517,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM1,607,000$28,910,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM300,000$28,755,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM527,600$28,205,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock2,000,000$27,660,000thousands by filing date
ZYMEWORKS INC98985W102COM578,100$27,321,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM240,000$26,916,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW1,850,873$26,875,000thousands by filing date
BIOXCEL THERAPEUTICS INC09075P105COM547,000$25,271,000thousands by filing date
ATRICURE INC04963C209COM446,600$24,862,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM1,239,000$24,817,000thousands by filing date
SOTERA HEALTH CO83601L102COM700,000$19,208,000thousands by filing date
CURIS INC231269200COM2,342,100$19,182,000thousands by filing date
SI BONE INC825704109COM639,884$19,133,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW4,000,000$17,800,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM5,726,000$17,522,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A965,300$17,057,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM303,000$16,483,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM1,248,000$15,725,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A125,690$15,538,000thousands by filing date
SURGERY PARTNERS INC86881A100COM531,000$15,404,000thousands by filing date
CERTARA INC COM15687V109Stock404,663$13,645,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM626,000$13,590,000thousands by filing date
CODEXIS INC192005106COM600,000$13,098,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM785,000$13,039,000thousands by filing date
OLEMA PHARMACEUTICALS INC68062P106COM270,000$12,982,000thousands by filing date
ONCOSEC MED INC68234L306COM1,952,000$12,590,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock347,645$11,354,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK392,000$10,404,000thousands by filing date
CASTLE BIOSCIENCES INC14843C105COMMON STOCK150,000$10,073,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,435,000$9,844,000thousands by filing date
SCYNEXIS INC811292200COM NEW1,255,000$9,601,000thousands by filing date
OAK STR HEALTH INC67181A107COM150,000$9,174,000thousands by filing date
GRITSTONE BIO INC39868T105COM2,122,064$8,361,000thousands by filing date
VESPER HEALTHCARE ACQSTN COR92538T203UNIT 99/99/9999600,000$7,272,000thousands by filing date
IGM BIOSCIENCES INC449585108COM80,000$7,063,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW62,100$6,176,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM519,645$5,836,000thousands by filing date
OUTSET MEDICAL INC690145107COM100,000$5,684,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN500,000$5,570,000thousands by filing date
ARYA SCIENCES ACQUISITION COG3166W106COM CL A500,000$5,425,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM250,000$5,175,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS400,000$5,124,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock300,000$5,103,000thousands by filing date
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK152,500$5,066,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK125,000$4,689,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM400,000$4,548,000thousands by filing date
LIFESCI ACQUISITION II CORP53229E103COM400,000$4,268,000thousands by filing date
PANACEA ACQUISITION CORP698102209UNIT 99/99/9999300,000$3,828,000thousands by filing date
BCTG ACQUISITION CORP05492W103COM300,000$3,432,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM92,574$3,131,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock40,000$2,822,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM50,000$2,742,000thousands by filing date
ANNEXON INC03589W102COM70,000$1,752,000thousands by filing date
ACCOLADE INC00437E102COM40,000$1,740,000thousands by filing date
BIOATLA INC09077B104COM50,000$1,701,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK50,000$1,644,000thousands by filing date
AMERICAN WELL CORP03044L105CL A50,000$1,267,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock30,000$1,247,000thousands by filing date
INOZYME PHARMA INC45790W108COM9,683$200,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-21-000002this filing2021-02-16acceptance time not in the bulk data set